230 related articles for article (PubMed ID: 31354722)
1. Bone Marrow NK Cells: Origin, Distinctive Features, and Requirements for Tissue Localization.
Bonanni V; Sciumè G; Santoni A; Bernardini G
Front Immunol; 2019; 10():1569. PubMed ID: 31354722
[TBL] [Abstract][Full Text] [Related]
2. Diversity of tissue-resident NK cells.
Peng H; Tian Z
Semin Immunol; 2017 Jun; 31():3-10. PubMed ID: 28802693
[TBL] [Abstract][Full Text] [Related]
3. CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow.
Sciumè G; De Angelis G; Benigni G; Ponzetta A; Morrone S; Santoni A; Bernardini G
Blood; 2011 Apr; 117(17):4467-75. PubMed ID: 21364193
[TBL] [Abstract][Full Text] [Related]
4. NK cell trafficking in health and autoimmunity:a comprehensive review.
Peng H; Tian Z
Clin Rev Allergy Immunol; 2014 Oct; 47(2):119-27. PubMed ID: 24366573
[TBL] [Abstract][Full Text] [Related]
5. Human Bone Marrow-Resident Natural Killer Cells Have a Unique Transcriptional Profile and Resemble Resident Memory CD8
Melsen JE; Lugthart G; Vervat C; Kielbasa SM; van der Zeeuw SAJ; Buermans HPJ; van Ostaijen-Ten Dam MM; Lankester AC; Schilham MW
Front Immunol; 2018; 9():1829. PubMed ID: 30186282
[TBL] [Abstract][Full Text] [Related]
6. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis.
Bengtsson M; Tötterman TH; Smedmyr B; Festin R; Oberg G; Simonsson B
Leukemia; 1989 Jan; 3(1):68-75. PubMed ID: 2535882
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow.
Keever CA; Welte K; Small T; Levick J; Sullivan M; Hauch M; Evans RL; O'Reilly RJ
Blood; 1987 Dec; 70(6):1893-903. PubMed ID: 3118990
[TBL] [Abstract][Full Text] [Related]
8. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets.
Bernardini G; Sciumè G; Bosisio D; Morrone S; Sozzani S; Santoni A
Blood; 2008 Apr; 111(7):3626-34. PubMed ID: 18227348
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
[TBL] [Abstract][Full Text] [Related]
10. Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment.
Ponzetta A; Benigni G; Antonangeli F; Sciumè G; Sanseviero E; Zingoni A; Ricciardi MR; Petrucci MT; Santoni A; Bernardini G
Cancer Res; 2015 Nov; 75(22):4766-77. PubMed ID: 26438594
[TBL] [Abstract][Full Text] [Related]
11. Exposure to an enriched environment promotes the terminal maturation and proliferation of natural killer cells in mice.
Meng Z; Liu T; Song Y; Wang Q; Xu D; Jiang J; Li M; Qiao J; Luo X; Gu J; Tu H; Gan Y
Brain Behav Immun; 2019 Mar; 77():150-160. PubMed ID: 30590110
[TBL] [Abstract][Full Text] [Related]
12. NK Cell-Specific Gata3 Ablation Identifies the Maturation Program Required for Bone Marrow Exit and Control of Proliferation.
Ali AK; Oh JS; Vivier E; Busslinger M; Lee SH
J Immunol; 2016 Feb; 196(4):1753-67. PubMed ID: 26773150
[TBL] [Abstract][Full Text] [Related]
13. Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution.
Vidriales MB; Orfao A; López-Berges MC; González M; Hernandez JM; Ciudad J; López A; Moro MJ; Martínez M; San Miguel JF
Ann Hematol; 1993 Nov; 67(5):217-22. PubMed ID: 7694663
[TBL] [Abstract][Full Text] [Related]
14. Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions.
Tsujimoto H; Uchida T; Efron PA; Scumpia PO; Verma A; Matsumoto T; Tschoeke SK; Ungaro RF; Ono S; Seki S; Clare-Salzler MJ; Baker HV; Mochizuki H; Ramphal R; Moldawer LL
J Leukoc Biol; 2005 Oct; 78(4):888-97. PubMed ID: 16033815
[TBL] [Abstract][Full Text] [Related]
15. CX3CR1 regulates the maintenance of KLRG1+ NK cells into the bone marrow by promoting their entry into circulation.
Ponzetta A; Sciumè G; Benigni G; Antonangeli F; Morrone S; Santoni A; Bernardini G
J Immunol; 2013 Dec; 191(11):5684-94. PubMed ID: 24184559
[TBL] [Abstract][Full Text] [Related]
16. Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrow.
Bernardini G; Sciumè G; Santoni A
Front Immunol; 2013; 4():12. PubMed ID: 23386850
[TBL] [Abstract][Full Text] [Related]
17. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
Hackett J; Bennett M; Kumar V
J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
[TBL] [Abstract][Full Text] [Related]
18. Tissue Determinants of Human NK Cell Development, Function, and Residence.
Dogra P; Rancan C; Ma W; Toth M; Senda T; Carpenter DJ; Kubota M; Matsumoto R; Thapa P; Szabo PA; Li Poon MM; Li J; Arakawa-Hoyt J; Shen Y; Fong L; Lanier LL; Farber DL
Cell; 2020 Feb; 180(4):749-763.e13. PubMed ID: 32059780
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow versus thymic pathways of natural killer cell development.
Di Santo JP; Vosshenrich CA
Immunol Rev; 2006 Dec; 214():35-46. PubMed ID: 17100874
[TBL] [Abstract][Full Text] [Related]
20. Effect of cyclosporin A on lymphopoiesis. III. Augmentation of the generation of natural killer cells in bone marrow transplanted mice treated with cyclosporin A.
Kosugi A; Shearer GM
J Immunol; 1991 Mar; 146(5):1416-21. PubMed ID: 1993836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
